Imatinib Completed Phase 2 Trials for Dermatofibrosarcoma Protuberans

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00243191Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans